Senotherapeutics for metabolic disease and diabetic complications is a research paper published in Journal of Internal Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Novo Nordisk Fonden
Grant: NNF23OC0084066
American Federation for Aging Research
Grant: Sagol Network GerOmic Award for Junior Faculty
The Swedish Diabetes Research Foundation
Grant: DIA2024-884
The US National Institutes of Health
Grant: R37AG013925
NIA NIH HHS
Grant: K01 AG090692
The US National Institutes of Health
Grant: R33AG061456
The Hevolution Foundation
Grant: HF-GRO-23-1199148-3
Novo Nordisk Foundation
Grant: unidentified
unidentified
Knut and Alice Wallenberg Foundation
Knut och Alice Wallenbergs Stiftelse
Robert J. and Theresa W. Ryan
Cedars-Sinai Medical Center
Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery
The Connor Fund
FWCI
1.99
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords